Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study

Piero Barbanti, Cinzia Aurilia, Massimo Filippi, Alberto Doretti, Florindo d’Onofrio, Paola Scatena, Rosario Vecchio, Roberta Messina, Luisa Vinciguerra, Angelo Ranieri, Francesco Baldisseri, Paola Torelli, Marco Russo, Carolina Cutrona, Giovanna Viticchi, Gabriella Egeo, Massimo Autunno, Francesca Pistoia, Cinzia Finocchi, Cecilia Camarda, Stefano Messina, Steno Rinalduzzi, Valeria Drago, Luigi Caputi, Monica Bandettini di Poggio, Simone Quintana, Antonio Salerno, Marco Bartolini, Giulia Fiorentini, Jesuely Spieckert de Souza, Fabrizio Di Stani, Stefano Bonassi, Annamaria Porreca, Unknown

Open source

DOI: 10.1007/s40120-026-00971-7
Published: 2026-06-09
Container: Neurology and Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-00971-7,
  title = {Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study},
  author = {Piero Barbanti and Cinzia Aurilia and Massimo Filippi and Alberto Doretti and Florindo d’Onofrio and Paola Scatena and Rosario Vecchio and Roberta Messina and Luisa Vinciguerra and Angelo Ranieri and Francesco Baldisseri and Paola Torelli and Marco Russo and Carolina Cutrona and Giovanna Viticchi and Gabriella Egeo and Massimo Autunno and Francesca Pistoia and Cinzia Finocchi and Cecilia Camarda and Stefano Messina and Steno Rinalduzzi and Valeria Drago and Luigi Caputi and Monica Bandettini di Poggio and Simone Quintana and Antonio Salerno and Marco Bartolini and Giulia Fiorentini and Jesuely Spieckert de Souza and Fabrizio Di Stani and Stefano Bonassi and Annamaria Porreca and Unknown},
  year = {2026},
  journal = {Neurology and Therapy},
  doi = {10.1007/s40120-026-00971-7},
  url = {https://doi.org/10.1007/s40120-026-00971-7}
}

RIS

TY  - JOUR
TI  - Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
AU  - Piero Barbanti
AU  - Cinzia Aurilia
AU  - Massimo Filippi
AU  - Alberto Doretti
AU  - Florindo d’Onofrio
AU  - Paola Scatena
AU  - Rosario Vecchio
AU  - Roberta Messina
AU  - Luisa Vinciguerra
AU  - Angelo Ranieri
AU  - Francesco Baldisseri
AU  - Paola Torelli
AU  - Marco Russo
AU  - Carolina Cutrona
AU  - Giovanna Viticchi
AU  - Gabriella Egeo
AU  - Massimo Autunno
AU  - Francesca Pistoia
AU  - Cinzia Finocchi
AU  - Cecilia Camarda
AU  - Stefano Messina
AU  - Steno Rinalduzzi
AU  - Valeria Drago
AU  - Luigi Caputi
AU  - Monica Bandettini di Poggio
AU  - Simone Quintana
AU  - Antonio Salerno
AU  - Marco Bartolini
AU  - Giulia Fiorentini
AU  - Jesuely Spieckert de Souza
AU  - Fabrizio Di Stani
AU  - Stefano Bonassi
AU  - Annamaria Porreca
AU  - Unknown
PY  - 2026
JO  - Neurology and Therapy
DO  - 10.1007/s40120-026-00971-7
UR  - https://doi.org/10.1007/s40120-026-00971-7
ER  -

APA

Barbanti, P., Aurilia, C., Filippi, M., Doretti, A., d’Onofrio, F., Scatena, P., Vecchio, R., Messina, R., Vinciguerra, L., Ranieri, A., Baldisseri, F., Torelli, P., Russo, M., Cutrona, C., Viticchi, G., Egeo, G., Autunno, M., Pistoia, F., Finocchi, C., Camarda, C., Messina, S., Rinalduzzi, S., Drago, V., Caputi, L., Poggio, M. B. D., Quintana, S., Salerno, A., Bartolini, M., Fiorentini, G., Souza, J. S. D., Stani, F. D., Bonassi, S., Porreca, A., & Unknown (2026). Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study. Neurology and Therapy. https://doi.org/10.1007/s40120-026-00971-7

Source records

crossref · retrieved 2026-11-08T09:48:09.279Z